ClinicalTrials.gg
Sign In

Drug

Daplusiran clinical trials

studies test it
12
open now
0
in phase 3
0
first study started
2019

How studies write it

Studies that test it under each name

Combined with it in one product

JNJ-73763989
12
JNJ-3989
5

Studies by the year they started

12 studies that test it; most in 2021 (5)

Studies that test daplusiran, by start year
YearStudies
20193
20203
20215
20221

By phase

A phase 1/2 study counts in both.

Phase 1
5
Phase 2
7

What it is tested for

Each study’s main condition, where its own words name it.

Hepatitis B, Chronic
7
Hepatitis D, Chronic
1

Who runs them

Industry 12 · Other 0

Janssen Research & Development, LLC (8) · Janssen Sciences Ireland UC (4)

Often tested with

Tested in the same studies.

Tomligisiran (12) · JNJ-56136379 (3) · JNJ-64300535 (1) · Immune Checkpoint Inhibitors (1)

Studies

Open first, then newest update. How each study uses daplusiran is read from its arms, and is right about nine times in ten.

Testing it · 12

Given in every arm · 1 — daplusiran is usual care beside what is tested

Codes

What other systems call daplusiran · ClinicalTrials.gg INT019039

  • UNII (FDA) HP2ZTB8W0FDAPLUSIRANOne source FDA
  • NCI Thesaurus C175765DaplusiranOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.